Happy 5th Birthday Mtech Access! On the 15th of November 2015 Mtech Access was registered at Companies House. 5 years on and we are thriving, demand for work is high...
Read More
We are delighted to announce that Mtech Access has been accepted as a corporate member of the British Healthcare Business Intelligence Association (BHBIA). At Mtech Access, we support our pharma...
Read More
We are delighted to announce the launch of our new Pharma Market Access Insights Podcast. In this podcast we will bring you insights from our associates across global healthcare, along with...
Read More
Each week, we brought together experts from across the NHS to share their experiences and insights with the industry in a free of charge webinar: 'How is COVID-19 impacting the...
Read More
Each year, on 11th February, the United Nations and the global scientific community celebrate the International Day of Women and Girls in Science. Women are underrepresented in science and are...
Read More
We understand that the path to successful global market access and uptake is complex and multi-faceted. Defining robust pricing and market access strategies, and developing meaningful value strategies, are essential...
Read More
Introducing David Thorne Director of NHS Insights & Interaction Originally a nurse, David has occupied board-level positions within both NHS hospitals and commissioning organisations. He was previously the Chief Executive...
Read More
Following the acquisition of Blue River Consulting we are pleased to announce that MD and owner David Thorne will be heading-up our NHS insights and interaction services at Mtech Access, bringing unparalleled hands-on experience and…
In order to comply with the EU regulation on medical devices, the regulatory stage Clinical Evaluation Report (CER) has been the focus of renewed attention by the medical device industry....
Read More
Partitioned survival analysis (PartSA) is currently the most commonly used modelling approach within HTA (health technology assessment) for advanced or metastatic cancers. However, until recently, there was no formal documentation…